2007
DOI: 10.1002/chir.20397
|View full text |Cite
|
Sign up to set email alerts
|

Role of racemization in optically active drugs development

Abstract: U.S. Food and Drug Administration issues certain guidelines for marketing of optically active drugs as some enantiomers racemize into human body, leading to the generation of other antipodes, which may be toxic or ballast to the human beings. Moreover, racemization reduces the administrated dosage concentration as optically active enantiomer converted into its inactive counter part. Therefore, the study of racemization of such type of drugs is an important and urgent need of today. This article describes in vi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
70
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 100 publications
(70 citation statements)
references
References 100 publications
0
70
0
Order By: Relevance
“…Racemization is a particular problem because its detection requires chiral analytical methods 13, 14. Hence, few reports disclose rate constants for racemization under aqueous conditions 1, 15, 16, 17, 18, 19, 20.…”
mentioning
confidence: 99%
“…Racemization is a particular problem because its detection requires chiral analytical methods 13, 14. Hence, few reports disclose rate constants for racemization under aqueous conditions 1, 15, 16, 17, 18, 19, 20.…”
mentioning
confidence: 99%
“…13 The interaction of two enantiomers of a chiral drug with metabolizing enzyme brings about two diastereomeric states of different probabilities. This enantioselective recognition may result in different pharmaceutical activities.…”
Section: Discussionmentioning
confidence: 99%
“…[13,14] Hence,f ew reports disclose rate constants for racemization under aqueous conditions. [1,[15][16][17][18][19][20] Chiral centers with certain combinations of substituents have been posited to be prone to general-basecatalyzed racemization although with little supporting data.…”
mentioning
confidence: 99%